Y43.1
Antineoplastic antimetabolites
⇄ Primary-code rule changed vs QĐ4469
Coding rules (TT06)
- ●Cannot be used as primary diagnosis
Coding guidance (WHO 2019)
Cytarabine
Sibling codes
Y43Primarily systemic agentsY43.0Antiallergic and antiemetic drugsY43.2Antineoplastic natural productsY43.3Other antineoplastic drugsY43.4Immunosuppressive agentsY43.5Acidifying and alkalizing agentsY43.6Enzymes, not elsewhere classifiedY43.8Other primarily systemic agents, not elsewhere classifiedY43.9Primarily systemic agent, unspecified